AAP
ALXN
Ardsley Advisory Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-2,500
| Closed | -$286K | – | 190 |
|
2020
Q3 | $286K | Buy |
+2,500
| New | +$286K | 0.06% | 94 |
|
2019
Q4 | – | Sell |
-2,500
| Closed | -$245K | – | 183 |
|
2019
Q3 | $245K | Sell |
2,500
-2,500
| -50% | -$245K | 0.05% | 93 |
|
2019
Q2 | $653K | Buy |
5,000
+1,500
| +43% | +$196K | 0.1% | 68 |
|
2019
Q1 | $473K | Buy |
+3,500
| New | +$473K | 0.09% | 73 |
|
2018
Q4 | – | Sell |
-114,000
| Closed | -$15.8M | – | 167 |
|
2018
Q3 | $15.8M | Sell |
114,000
-13,000
| -10% | -$1.81M | 2.14% | 13 |
|
2018
Q2 | $15.8M | Sell |
127,000
-20,000
| -14% | -$2.48M | 2.37% | 11 |
|
2018
Q1 | $16.4M | Sell |
147,000
-37,000
| -20% | -$4.12M | 2.46% | 11 |
|
2017
Q4 | $22M | Buy |
184,000
+12,500
| +7% | +$1.49M | 2.67% | 4 |
|
2017
Q3 | $24.1M | Sell |
171,500
-5,000
| -3% | -$701K | 3.2% | 3 |
|
2017
Q2 | $21.5M | Buy |
176,500
+174,500
| +8,725% | +$21.2M | 3.34% | 4 |
|
2017
Q1 | $242K | Buy |
+2,000
| New | +$242K | 0.04% | 103 |
|